Navigation Links
Resverlogix Notice of Conference Call & Webcast
Date:8/21/2008

TSX Exchange Symbol: RVX

CALGARY, Aug. 21 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that it will host a live teleconference on August 25, 2008 at 11:00 am MDT to provide a corporate update of the Company. Following the presentation there will be a live question and answer session.

The webcast can be accessed at the following link:

http://services.choruscall.com/links/resverlogix080825.html

Participants can also dial in for the conference call:

Dial information is as follows:

North American Toll Free Dial In: 1-800-319-4610

International Dial In: +1-604-638-5340

The webcast will be available on the Resverlogix website for replay for a period of 10 days after the event.

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer's and other vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a program that aims to address burgeoning grievous diseases, such as cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit http://www.resverlogix.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of Resverlogix Corp. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Jan Gray Joins Resverlogix Board of Directors
2. Resverlogixs Lead Drug Featured in Key Scientific Publication
3. Industry Leaders Select Resverlogixs RVX-208
4. /C O R R E C T I O N from Source -- Resverlogix Corp./
5. Resverlogix Notice of Conference Call & Webcast
6. Resverlogix Share Option Extension
7. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
8. Resverlogix Honoured with World Economic Forum Technology Pioneer Award
9. Resverlogix is Presenting at IAS HDL Workshop
10. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
11. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...,s University Belfast is to become the United King... counter malicious ,cyber-attacks, after a funding...Research Council. , Almost 7m from the EPSRC wi... - the Centre for Secure Information Technologies ...of Electronics, Communications and Information Tec...
(Date:11/21/2008)... promise of quantum computing is that it will dram...g certain key problems: searching large databases,...es and simulating the atomic structure of material... pardon the pun, has been taken by Stanford resear...shed in the journal Nature . Working in the Ginzt...
(Date:11/21/2008)... Calif., Nov. 21 BioMari...ounced that Dr. Emil Kakkis, its Chief Medical,Of... 2009. Dr. Kakkis has,decided to leave his posit...evote more of his time to personal endeavors relat... be a consultant for the company for the foreseeab...
(Date:11/21/2008)...E, Calif., Nov. 21 VNUS(...a leading provider of medical devices for,the min..., today announced its,plans to present at the Pip...e,held December 2-3, 2008, at The New York Palace...will be Brian Farley, President and Chief Executiv...
Breaking Biology Technology:Queen's secures £25M for UK's cyber safety 2Stanford: Quantum computing spins closer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4
...ire, WI-- Silicon Logic Engineering has joined f... to offer improved custom computer chip verificati...usiness collaboration is meant to speed up design ...nal manufacturing operations due to undetected err...egrated circuit) designs. , ,This collaboration u...
...logy is just some passing fad (particularly in the...ss and its here to stay. More than that, its a glo...ks the growth of biotech around the globe is the a...itte & Touche , but even though guys are heavily i...uts out the best information on the biotech sector...
...ommerce will speak to cutting-edge Madisonians Thu...meeting, held at Club Majestic, 115 King Street in...i, New York Times e-commerce columnist, will speak...fter the boom and bust beginning in the mid-90s, h... please consumers and make a profit at the same ti...
...d required regulatory approvals for the $2.3 billi...e company has agreed to divest of two divisions o...ems, a medical imaging equipment manufacturer plan...ical Systems Information Technologies under the ma...red regulatory approvals, including those of the U...
Other Biology Technology:Silicon Logic Teams Up to Save Money 2The Impact of Biotech Globalization in the Midwest 2The Impact of Biotech Globalization in the Midwest 3The Impact of Biotech Globalization in the Midwest 4
(Date:11/23/2008)... November 23, 2008 -- Peregrine Pharmaceuticals, I...ata in Nature Medicine that supports the broad a...osphatidylserine (anti-PS) antibody platform, show...e lethal virus infections in animal disease models...treatment of hepatitis C virus (HCV) infection and...
(Date:11/23/2008)...ls pain by activating a set of proteins known as c...tite, inflammation, and memory. The body also has ... activate these same receptors, namely N-arachidon...(2-AG). These natural components of the cannabinoi...velop new treatments not only for chronic pain, bu...
(Date:11/23/2008)...Hybrid plants, like corn, grow bigger and better t...photosynthesis and starch metabolism are more acti...versity of Texas at Austin in a new study publishe...relevance in many areas of agriculture, and could ...uels and seed production for animal feedstock and ...
(Date:11/22/2008)...rgentina Current research suggests that melatonin...tory eye disease. The related report by Sande et a...al Uveitis," appears in the December issue of The ...veitis develop sudden redness and pain in their ey...ted, uveitis can lead to permanent vision loss, ac...
Breaking Biology News(10 mins):Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections 2Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections 3Scripps research team defines new painkilling chemical pathway 2Plants grow bigger and more vigorously through changes in their internal clocks 2Melatonin may save eyesight in inflammatory disease 2Johnson 26 Johnson to Webcast Annual Meeting of Shareholders 17408 1bioMETRX Inc Initiates Integration of Personnel and Assets of Sequiam Corp 4768 1bioMETRX Inc Initiates Integration of Personnel and Assets of Sequiam Corp 4768 2Glass Lewis 26 Co Recommends Renovis Shareholders Vote For Merger With Evotec 4763 1Glass Lewis 26 Co Recommends Renovis Shareholders Vote For Merger With Evotec 4763 2Glass Lewis 26 Co Recommends Renovis Shareholders Vote For Merger With Evotec 4763 3Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A CYRX RHWI 17401 1Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A CYRX RHWI 17401 2
...he research Dr. Kornberg did will help open the do...ts, including cancer, heart disease and inflammati...m cells and their potential for therapeutic applic...ey role of chemistry in the scientific research in...tures revealing how the genetic information stored...
...e popular hair-growth drug finasteride, taken by m...sults of the prostate-specific antigen (PSA) test,...a multicenter study has found. , The study, invol...d, is available online in the British medical jour...ter Jan. 1, 2007. The study calls for new clinical...
...w research identifies an important gene that influ...s in the brain. The study, funded by National Ins...American College of Neuropsychopharmacology,s Annu... associate professor of psychiatry and her colleag...crease activity of a molecule called CREB in a bra...
...ientists at the University of York are to play a p...owing environmental problem caused by discarded li...e of modern life, appearing in everything from poc...en televisions. , But the liquid crystals they ...l advances are so rapid that society is already di...
Other Biology News:Comments, experts and background on the 2006 Nobel Prize in chemistry 2Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds 2New research identifies gene important for nicotine's effects on the brain 2Recycling technology 2
...tibody detects an ~185 kDa protein, corresponding ...lated at tyrosine 1248 on SDS-PAGE immunoblots. Th...d against the non-phosphorylated peptide to remove... form of the protein. In cell lines where EGFR is...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645
LightCycler ® 2.0 Instrument; PCR amplification system and detection system from Roche Applied Science
...all the accessories necessary for casting gels for...n polymorphism analysis (SSCP) with the DCode univ...a cooling finger adaptor for use with an external ...sets of 0.75 mm spacers, two 20-well 0.75 mm combs...
Biology Products: